News

Copan announced this week that it has received the Japanese patent for its use of flocking technology to manufacture its line of flocked swabs (FLOQSwabs™).

Copan is proud to announce the 30th placement of a Walk-Away Specimen Processor (WASP^®), at Eastern Health, Newfoundland, in Canada. The WASP^® is a revolutionary instrument used for automatically planting and streaking bacteriology samples. So far, WASP^® processors have been successfully installed, with favorable reviews, throughout North America and Europe, including the United States, Canada, Belgium, Italy, UK, Holland, and France, among others.

Copan Diagnostics, Inc. has recently launched a totally new website as the company continues to grow and diversify. In the spirit of innovation and creativity, Copan’s new site is filled with informational tools, such as scientific studies, educational training videos, brochures, news and events, technical information, and more. The main focus of Copan Diagnostics’ new website is an improved user experienc

Endorsement of Copan nasopharyngeal Flocked Swabs as the specimen of choice for Influenza testing follows the publication of numerous clinical studies that demonstrate equivalent or better test results when compared with NP aspirates or washes.

Despite tough economic times, Copan is proud to announce the expansion of its US operations. A new multimillion dollar investment project is being undertaken to bring plastic transfer pipet and additional medical device manufacturing operations to Copan Diagnostics, in Murrieta, California. The expansion plan includes the addition of blow molding machinery to expand Copan’s current capabilities, as well as to create local jobs.